Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001188919-25-000006
Filing Date
2025-12-10
Accepted
2025-12-10 17:03:23
Documents
1
Period of Report
2025-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1424
  Complete submission text file 0001188919-25-000006.txt   3150
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
LOVE TED W (Reporting) CIK: 0001188919 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33500 | Film No.: 251562656

Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)